A. Brew Atkinson

3.2k total citations
45 papers, 2.0k citations indexed

About

A. Brew Atkinson is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A. Brew Atkinson has authored 45 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A. Brew Atkinson's work include Pituitary Gland Disorders and Treatments (18 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Adrenal Hormones and Disorders (9 papers). A. Brew Atkinson is often cited by papers focused on Pituitary Gland Disorders and Treatments (18 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Adrenal Hormones and Disorders (9 papers). A. Brew Atkinson collaborates with scholars based in United Kingdom, United States and Ireland. A. Brew Atkinson's co-authors include B. Sheridan, David R. McCance, Laurence Kennedy, M Ivan Wiggam, C Boreham, Helen M. Whitehead, David R. Hadden, Adele Kennedy, P. M. Bell and C. H. Courtney and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

A. Brew Atkinson

44 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Brew Atkinson United Kingdom 22 1.4k 445 295 244 224 45 2.0k
William Drake United Kingdom 25 1.5k 1.1× 527 1.2× 193 0.7× 460 1.9× 201 0.9× 83 2.2k
P E Belchetz United Kingdom 23 1.7k 1.2× 362 0.8× 169 0.6× 279 1.1× 270 1.2× 55 2.4k
Libuse Tauchmanovà Italy 30 1.6k 1.2× 1.0k 2.3× 119 0.4× 325 1.3× 218 1.0× 83 3.2k
Indraneel Banerjee United Kingdom 23 1.3k 1.0× 493 1.1× 109 0.4× 454 1.9× 156 0.7× 110 1.9k
S Shalet United Kingdom 29 1.5k 1.1× 389 0.9× 331 1.1× 539 2.2× 153 0.7× 53 2.9k
G. Plewe Germany 14 1.1k 0.8× 329 0.7× 223 0.8× 350 1.4× 204 0.9× 19 1.6k
Rama Walia India 22 855 0.6× 510 1.1× 106 0.4× 354 1.5× 334 1.5× 125 1.7k
Michael M. Ritter Germany 18 551 0.4× 476 1.1× 126 0.4× 206 0.8× 259 1.2× 43 1.2k
Wojciech Zgliczyński Poland 23 1.3k 1.0× 502 1.1× 72 0.2× 207 0.8× 232 1.0× 170 1.9k
Tapani Ebeling Finland 20 1.5k 1.1× 1.0k 2.3× 97 0.3× 267 1.1× 417 1.9× 46 2.2k

Countries citing papers authored by A. Brew Atkinson

Since Specialization
Citations

This map shows the geographic impact of A. Brew Atkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Brew Atkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Brew Atkinson more than expected).

Fields of papers citing papers by A. Brew Atkinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Brew Atkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Brew Atkinson. The network helps show where A. Brew Atkinson may publish in the future.

Co-authorship network of co-authors of A. Brew Atkinson

This figure shows the co-authorship network connecting the top 25 collaborators of A. Brew Atkinson. A scholar is included among the top collaborators of A. Brew Atkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Brew Atkinson. A. Brew Atkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Atkinson, A. Brew, et al.. (2013). Effects on Insulin Action of Adding Low-Dose Thiazide to Angiotensin-Converting Enzyme Inhibitor in Essential Hypertension. Hypertension. 61(4). 800–805. 2 indexed citations
4.
Chahal, Harvinder, Karen Stals, Martina Unterländer, et al.. (2011). AIPMutation in Pituitary Adenomas in the 18th Century and Today. New England Journal of Medicine. 364(1). 43–50. 94 indexed citations
5.
Courtney, C. H., et al.. (2008). All patients with ‘idiopathic’ hypopituitarism should be screened for hemochromatosis. Pituitary. 12(3). 273–275. 12 indexed citations
6.
Mullan, Karen & A. Brew Atkinson. (2007). Endocrine clinical update: Where are we in the therapeutic management of pituitary‐dependent hypercortisolism?. Clinical Endocrinology. 68(3). 327–337. 11 indexed citations
7.
Mallidis, Con, Ishola Agbaje, Deirdre Rogers, et al.. (2007). Distribution of the receptor for advanced glycation end products in the human male reproductive tract: prevalence in men with diabetes mellitus. Human Reproduction. 22(8). 2169–2177. 95 indexed citations
8.
Mullan, Karen, A. Brew Atkinson, & B. Sheridan. (2007). Cyclical Cushing's syndrome: an update. Current Opinion in Endocrinology Diabetes and Obesity. 14(4). 317–322. 15 indexed citations
9.
Atkinson, A. Brew, Adele Kennedy, M Ivan Wiggam, David R. McCance, & B. Sheridan. (2005). Long‐term remission rates after pituitary surgery for Cushing's disease: the need for long‐term surveillance. Clinical Endocrinology. 63(5). 549–559. 211 indexed citations
10.
Courtney, C. H., David R. McCance, A. Brew Atkinson, et al.. (2003). Effect of the alpha-adrenergic blocker, doxazosin, on endothelial function and insulin action. Metabolism. 52(9). 1147–1152. 20 indexed citations
11.
12.
Atkinson, A. Brew. (1999). The role of bilateral inferior petrosal sinus sampling in the investigation of ACTH‐dependent hypercortisolism. Clinical Endocrinology. 51(2). 149–150. 2 indexed citations
13.
Hunter, Steven, Roy Harper, C. N. Ennis, et al.. (1998). Effects of combination therapy with an angiotensin converting enzyme inhibitor and thiazide diuretic on insulin action in essential hypertension. Journal of Hypertension. 16(1). 103–109. 25 indexed citations
14.
Hunter, Steven, Roy Harper, C. N. Ennis, et al.. (1997). Skeletal muscle blood flow is not a determinant of insulin resistance in essential hypertension. Journal of Hypertension. 15(1). 73–77. 10 indexed citations
15.
Roberts, Susan B., Paul Fuss, Gerard E. Dallal, et al.. (1996). Effects of Age on Energy Expenditure and Substrate Oxidation During Experimental Overfeeding in Healthy Men. The Journals of Gerontology Series A. 51A(2). B148–B157. 58 indexed citations
16.
McKnight, John, David R. McCance, B. Sheridan, & A. Brew Atkinson. (1995). Four years' treatment of resistant acromegaly with octreotide. European Journal of Endocrinology. 132(4). 429–432. 10 indexed citations
17.
Hunter, Steven, William H. Daughaday, Michael E. Callender, et al.. (1994). A case of hepatoma associated with hypoglycaemia and overproduction of IGF‐II (E‐21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin. Clinical Endocrinology. 41(3). 397–401. 32 indexed citations
18.
McCance, David R., C F J Russell, T Kennedy, et al.. (1993). Bilateral adrenalectomy: low mortality and morbidity in Cushing's disease. Clinical Endocrinology. 39(3). 315–321. 72 indexed citations
19.
Whitehead, Helen M., et al.. (1992). Growth hormone treatment of adults withgrowth hormone deficiency: results of a 13‐month placebo controlled cross‐over study. Clinical Endocrinology. 36(1). 45–52. 308 indexed citations
20.
Wilkinson, Mark, et al.. (1992). Normolipaemic plane xanthomas: an association with increased vascular permeability and serum lipoprotein(a) concentration. Clinical and Experimental Dermatology. 17(3). 211–213. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William Drake Breakdown of academic impact, for papers by P E Belchetz Breakdown of academic impact, for papers by Libuse Tauchmanovà Breakdown of academic impact, for papers by Indraneel Banerjee Breakdown of academic impact, for papers by S Shalet Breakdown of academic impact, for papers by G. Plewe Breakdown of academic impact, for papers by Rama Walia Breakdown of academic impact, for papers by Michael M. Ritter Breakdown of academic impact, for papers by Wojciech Zgliczyński Breakdown of academic impact, for papers by Tapani Ebeling
Rankless by CCL
2026